Objective: To investigate the physiological role of cAMP-dependent protein kinase A (PKA)-mediated, cardiac myosin binding protein C (MyBP-C) phosphorylation. Methods: A cardiac MyBP-C cDNA lacking nine amino acids, which contained a phosphorylation site, was made, and subsequently used to generate multiple lines of transgenic mice. Upon confirming that a partial replacement of endogenous protein with transgenic protein occurred, the biochemical and physiological consequences were studied. PKA-dependent phosphorylation assays were used to estimate the phosphorylation states of major cardiac PKA substrates. Myofibril Mg-ATPase activities were also measured. Isolated working heart and whole animal exercise studies were used to measure the physiological changes. Results: Transgenic mice displayed a compensatory response, with PKA-mediated phosphorylation of both troponin I and phospholamban showing significant 21 increases. The remaining endogenous cardiac MyBP-C also showed increased phosphorylation levels. Maximal Mg -ATPase activity was increased. Significant functional changes at both the whole organ and whole animal levels also occurred. Parameters reflecting cardiac contractility and relaxation increased about 22 and 25%, respectively, in the mutant relative to wild type mice (n55, P,0.001). In young adults the capacity for stress exercise, quantitated using an exercise treadmill regimen, was substantially enhanced (n56, P,0.01). Conclusions: Cardiac MyBP-C phosphorylation plays an important physiological role and that the protein's degree of phosphorylation is coordinated with the phosphorylation levels of other proteins within the contractile apparatus.
Introduction
switch, which is made up of the thin filament protein tropomyosin and the three subunits of troponin. Upon 21 It is well-established that generation of force and power binding Ca , the accessing state of the molecular motor, in striated muscle in general, and cardiac muscle in myosin, which is located in the thick filament, is modified particular, depends upon the thick and thin filaments such that it productively binds to actin, which is located in interacting within a well organized sarcomere. Relaxation the thin filament [1] . and contraction in cardiac muscle depend upon the conIt is now well established that b-adrenergic stimulation, trolled transition between resting and force-generating either in intact hearts or in isolated myocardial cells, 21 states. This control is mediated by a Ca -dependent results in phosphorylation of MyBP-C [2] and the inhibitory subunit of troponin (TnI) [3] , which are located in the thick and thin filaments, respectively. These post-translational modifications can have significant chronotropic, *Corresponding author. Tel.: 11-513-636-8098; fax: 11-513-636-inotropic and lusitropic effects. However, the role or roles 3852 . E-mail address: jeff.robbins@chmcc.org (J. Robbins). 1 Present address: Cardiovascular Research Institute, Morehouse School of Medicine, Westview Dr. SW, Atlanta, GA 30310, USA.
Time for primary review 16 days. 21 phosphorylation of these proteins plays in the Ca -inMyBP-C fragment into the skinned fibers. In contrast, we dependent regulation of cardiac contractility in vivo is not are interested in understanding the structure-function well understood.
relationships of these post-translational modifications, and MyBP-C, a major component of the thick filament, how other components of the contractile apparatus might binds to both the myosin (thick) and titin filament systems.
react and compensate for any changes in the phosphorylaDiscovered over 27 years ago [4] , interest in the protein's tion of the cardiac-specific domain of MyBP-C in vivo. In role(s) intensified after multiple mutations in the polythis study, we generated multiple lines of TG mice that peptide were linked to familial hypertrophic carexpress a MyBP-C that lacks the cardiac-specific phos-
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diomyopathy [5] . MyBP-C is localized in the C region of phorylation domain (MyBP-C ). These mice were comthe A band, and has a unique organization with seven to pared against both non-transgenic (NTG) and TG cohorts nine axial bands in each half-sarcomere. Like other myosin that expressed normal, wild-type MyBP-C [12, 13] . The binding proteins and titin, MyBP-C belongs to the intraceldata show the in vivo functionality of this domain, and the lular immunoglobulin (Ig) superfamily and is composed of interactions of the molecule's phosphorylation state with repeated Ig and fibronectin domains [6] . In vitro modeling respect to phosphorylation of other sarcomeric proteins, and reconstitution experiments, as well as experiments TnI and phospholamban, which function in controlling carried out using cell transfections, indicate that the protein cardiac contractility. Long-term insufficiency of MyBP-C probably plays an important role in assembling and phosphorylation was quite benign, with no detectable maintaining the overall architecture of the sarcomere [7, 8] .
hypertrophy at the cardiomyocyte level; in fact, improveHowever, the cardiac-specific isoform may also play an ment of performance, as measured by a stress exercise important role in the heart's response to b-adrenergic regimen, occurred. It appears that cardiac MyBP-C phosstimulation. While the skeletal muscle isoform has a single phorylation can play a role in regulating overall organ site that can be phosphorylated via the cAMP-dependent function and is coordinated closely with the phosphoryla- 21 protein kinase (PKA) and / or Ca / calmodulin-dependent tion states of the other cardiac contractile regulatory (CAMKII) kinases, the cardiac isoform has four potential proteins. sites, whose phosphorylation can change both filament orientation and contractile mechanics [2, 7, 9, 10] . One site, located at the cardiac isoform-specific insertion that forms 2. Methods a surface loop [2] , is particularly interesting. When deleted or mutated, cardiac MyBP-C phosphorylation is markedly 2.1. Transgene construction decreased. Thus, phosphorylation at this site may function as a conformational switch, rendering other sites on the The full-length, c-myc-tagged murine cardiac MyBP-C protein more accessible to the relevant kinase [2] .
cDNA has been described [12] . The sequence found in the With the exception of gain-of function approaches to human MyBP-C, LAGGGRRIS reads LAGAGRRT S in study the potential dominant negative effects of some FHC the mouse. The cardiac MyBP-C with the deletion of this mutations [11] [12] [13] , studies concerning the structure-funcnine-amino acid domain was generated using the overlaption relationships of this modular protein have been carried ping PCR method with flanking primers. All PCR products out in vitro using either transfection of cell culture with were sequenced completely and the fragments linked to the cDNAs [8] or biochemically defined filament reconstitumouse a-myosin heavy chain promoter (a-MyHC) ( Fig.  tions with fragments of the protein [9] . X-ray diffraction 1A). The final constructs were digested free of vector analysis on thick filaments showed that the phosphorylasequence with NotI, purified from agarose gels and used to tion state of MyBP-C affects cross bridge extension and generate transgenic mice. The investigation conforms to increases the overall order of the thick filament [14] . The the Guide for the Care and Use of Laboratory Animals authors suggested that phosphorylation of residues within published by the US National Institutes of health (NIH the regulatory motif of MyBP-C changes the end-to-end Publication No. 85-23, revised 1996). interactions of adjacent molecules within the thick filament. This, in turn, may change the orientation or flexibili-2.2. Phosphorylation assays ty of the crossbridges, altering the rate constants of attachment / detachment [10, 14] . Using a variety of bioDetergent-extracted cardiac myofibrils were prepared chemical and in vitro approaches, Gautel and co-workers from frozen hearts. A protease inhibitor cocktail (Boehdemonstrated the potential importance of phosphorylation ringer-Mannheim, Indianapolis, IN) was included in all of this domain in regulating filament mechanics, noting isolation buffers. Only freshly prepared myofibrils samples that five of the six parameters measured were modified were used. Ten mg of myofibril protein were used in the when exchanging the phosphorylated and non-phosphosphorylation assays as described [15] with minor phorylated fragments [9] .
modifications. For the back-phosphorylation assays,
32
The above studies were performed in skeletal muscle myofibril proteins were incubated after adding [g-P]ATP fibers and involved infusing high doses of a soluble (15 mCi / reaction, reaction volume 15 ml), and the catalytic were quantitated as described previously [12] . (C) Western analysis of MyBP-C.wt and MyBP-C expression. Myofilament proteins were extracted [30], 5 mg loaded onto a 7% SDS-PAGE gel and transferred to nitrocellulose membranes for Western blot analyses using antic-myc monoclonal antibody to detect the TG proteins.
subunit of cAMP-dependent protein kinase (PKA catalytic autoradiography. Protein loading was normalized to actin, subunit, 30 U) for 50 min at 308C. A series of preliminary as quantified by scanning densitometry. Radioactive signal experiments were done to ensure these conditions resulted was quantitated using a StormImager860 (Molecular Dy-32 in maximal P incorporation. Basal phosphorylation was namics, Sunnyvale, CA). Maximal PKA-dependent phosminimal in the presence of calyculin A (0.1 mM) and phorylation was determined by pretreatment with alkaline Na VO (1 mM). Boiling for 5 min in gel-loading buffer phosphatase (AP) followed by treatment with the PKA then separated by 12% SDS-PAGE. Gels were fixed, AP added (1:100 enzyme:protein) and the reaction carried stained with Colloidal Brilliant Blue and then subjected to out for 30 min at 378C. Calyculin A and Na VO were added after dephosphorylation. Samples were heated at 30-40% substitution of endogenous MyBP-C with MyBP-
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658C for 15 min to ensure the termination of the de-C . 32 phosphorylation reaction. Negligible amounts of P inPrevious studies in which FHC mutations in MyBP-C corporation occurred in AP-treated samples that were not were expressed in cardiomyocytes showed significant heated. The phosphorylation levels of phospholamban alterations in the pattern of protein incorporation in the were also measured by PKA back phosphorylation using sarcomere, as revealed by immunofluorescent staining 20 mg of isolated sarcoplasmic reticulum [15] .
using anti-C-Myc antibody, coupled with confocal micro-D9 scopy [12, 13] . In contrast with those results, MyBP-C 21 2.3. Actomyosin Mg ATPase assays was capable of incorporating into the A-band of the sarcomere in a pattern that was essentially indistinguish- 21 Myofibrillar actomyosin Mg ATPase activity was deable from that of the endogenous protein (Fig. 2) . There termined by measuring inorganic phosphate release as was no apparent disruption of sarcomeric structure, as described by Dobrowolski et al. [16] and Wattanapermpool detected by immunofluorescent staining (Fig. 2) and by [17] with slight modifications. Assays were carried out in standard light and electron microscopy (data not shown). 21 96-well microtiter plates at pCa concentrations of Consistent with these data, when we determined the cell 8.000-4.875 at room temperature during the linear P volume, profile area and length, the sarcomere length, as i release phase of the reaction. well as the transverse sectional area and cardiomyocyte minor and major diameter using CoulterE Sizer analyses and computer-aided image analysis, no statistically signifi-3. Results cant differences presented (data not shown), indicating that, if any hypertrophic response occurs, it is subtle, not 3.1. Generation of mice carrying MyBP-C transgenes fully penetrant and certainly does not lead to any overt pathology. Two constructs were used in these studies (Fig. 1A) .
The full-length, wild-type MyBP-C cDNA was used 3.2. Partial substitution with MyBP-C alters previously to generate TG mice [12, 13] and a cohort of endogenous phosphorylation levels these animals served as a control to rule out any epiphenomena arising merely as a result of TG expression of To determine the in vivo consequences of the phosMyBP-C. Both lines were tagged with c-Myc such that the phorylation domain's deletion in cardiac MyBP-C, we
TG-encoded protein could be distinguished from endogenperformed phosphorylation assays using MyBP-C ous MyBP-C. In comparing the mouse and human seMyBP-C.wt and NTG mice. As expected, both back and quences for the protein's cardiac isoform, we noted that the maximal PKA-dependent phosphorylation of myofibril
nine-amino acid residues comprising a serine phosphorylasamples from the MyBP-C mice were decreased (Fig. 3) . tion site in the cardiac-specific sequences present in the Maximal phosphorylation (Fig. 3A) , a measure of the total amino termini were almost completely conserved. Sub-PKA-dependent phosphorylation sites in the protein, was D9 sequently, we generated a MyBP-C cDNA (MyBP-C ) in decreased by 35%, which corresponds well to the estiwhich these nine amino acids were deleted. The cDNA mated degree of replacement of the endogenous protein was then linked to the a-MyHC promoter [18] and used to with the TG species. In the back phosphorylation assay,
generate TG mice. Three MyBP-C TG lines expressing which gives one an estimate of the phosphorylated sites in the transgene at different levels were generated and the the isolated MyBP-C protein pools, values obtained with D9 degree of expression relative to the endogenous MyBP-C the MyBP-C myofibril samples were decreased by transcripts was established (Fig. 1B) . Modest differences approximately 65%, relative to the NTG and MyBP-C.wt were observed between the three lines, with transcript samples (Fig. 3B) . Thus, as expected, there are fewer sites levels varying from 1.5-to 3.5-fold with respect to the on the total MyBP-C population available for PKA-depenendogenous mRNA. These expression levels were sigdent phosphorylation due to the partial substitution of D9 nificantly below the level (5-fold) observed for the wildendogenous MyBP-C with MyBP-C . Additionally, the type over-expressor. Western blot analyses of myofibril significant decrease in the back-phosphorylation studies protein extracted from the TG lines (8-12 weeks) were (65%), relative to the decreases in the maximal phoscarried out using anti-C-Myc monoclonal antibody in order phorylation values (35%), implies that the remaining, to detect the TG proteins (Fig. 1C) . The data confirm the endogenous protein is highly phosphorylated, certainly correct size of the transgenically encoded polypeptides. more so than in the NTG and MyBP-C cohorts. The mutant MyBP-C protein appears to be stable and the The phosphorylation states of other contractile proteins protein levels from the three lines correspond roughly to that function as potential regulators of contractility were their transcript levels (Fig. 1C) . Based on standard curves also examined. Maximal phosphorylation of TnI was not performed with MyBP-C.wt, we estimate that the highest decreased and maximal phosphorylation of phospholamban expressing lines (lines 156 / 157) resulted in approximately (PLB), derived from sarcoplasmic reticulum, was unaffect-ed (data not shown). However, the back phosphorylation D9 studies showed that in the MyBP-C mice significant decreases in both TnI and PLB presented (Fig. 3C) . Since the back-phosphorylation assay reflects the degree of phosphorylation of the isolated proteins, the data indicate that these endogenous proteins also appear to be more highly phosphorylated relative to the MyBP-C.wt and NTG control cohorts. We next examined the ATPase
activities present in the NTG, MyBP-C.wt and MyBP-C experimental cohorts. While the MyBP-C.wt mice were statistically indistinguishable for the NTG controls, the
MyBP-C line showed a significant increase in maximal ATPase activity (Fig. 4) . These results are consistent with previous data indicating that phosphorylation of MyBP-C decreased actin-activated myosin ATPase activity [19] .
Cardiac function
In an attempt to detect functional changes that might occur in response to the partial inability of MyBP-C to respond to b-adrenergic stimulation, both Langendorff and working heart [20] preparations were carried out on the three experimental cohorts. In the mature adults (15-25 weeks), differences in contractility and relaxation (6dP/ dt) presented (Table 1 ). The increases in contractility in
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the MyBP-C mice are consistent with the increased ATPase values. However, when similar experiments were carried out in an intact, closed chest model, no differences in cardiac responses to b-agonist stimulation could be observed (data not shown). It should be noted, however, that the neural-humoral axis would be intact in those animals, and therefore it is likely that the system can compensate, at least during the short period (30-180 min) during which the experiment takes place. Maintenance of function may therefore reflect alterations in the phosphorylation levels of the other proteins able to participate 21 in Ca -independent regulation of contractile function.
The above assays are all performed under acute conditions. We reasoned that intermittent cardiac stress over a prolonged period might point out some of the physiological consequences of an altered response to b-adrenergic stimulation and the ability of the animals to perform during a stress exercise regimen was tested. Quantitation of performance during repeated trials on a motorized treadmill apparatus has proven to be a useful measurement of a transgenic animal's capability to exercise [13, 21] . Young adult (16 week) mice were acclimated to the treadmill over a 2-week period. They were then exercised for 50 min twice per week over a 5-week period (Fig. 5) . Implantable to the MyBP-C.wt and NTG controls (Fig. 5) . samples of 12-week MyBP-C mice, compared with age-matched MyBP-C.wt and NTG control. Myofibril proteins were derived from total hearts and the D9 data normalized for protein loading using the Coomassie-stained gels as reference. Note the less intense MyBP-C bands in the MyBP-C lanes relative to the MyBP-C.wt and NTG controls. Scanning densitometry using NIH ImageQuant software generated the histograms to the right. (B) PKA-dependent back D9 phosphorylation assays. (C) Sarcoplasmic reticulum was isolated from MyBP-C , MyBP-C.wt and NTG mice and used to carry out PKA-dependent back phosphorylation assays for PLP. The histogram for TnI was generated using the data in (B). All bars represent the mean6S.E. n54 for each cohort (*P,0.05).
Discussion
observable phenotype is not simply an epiphenomenon of TG expression are the data obtained from the TG control In this study, we utilized a transgenic approach in cohort, in which wild-type MyBP-C is expressed at levels dissecting structure function relationships in cardiac higher than those observed for the construct under study:
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MyBP-C. As in previous experiments where a contractile in this case, MyBP-C . Long-term diminished cardiac protein is expressed in a cardiac-specific manner at high MyBP-C phosphorylation in vivo results in increased levels [12, 13, 18, 22] , the cardiomyocyte regulates the proendogenous phosphorylation in at least three major cardiac tein's stoichiometry such that TG expression results, not in proteins (MyBP-C, TnI and PLB) that are involved in 'over-expression' but rather in a dose-dependent (partial) adrenergic regulation of cardiac contraction. Within the replacement of the endogenous protein with the transgenicontext of the isolated working heart, as well as the whole cally encoded species. Emphasizing the fact that any animal, statistically significant increases in performance weeks), consisting of line 156, MyBP-C.wt, and NTG animals were used. Six animals from each group were subjected to a series of runs on a motorized treadmill as described previously [21] . Mice were acclimated were noted. The modifications are, for the most part, fairly to the treadmill over a 2-week period before the experimental trial began.
benign and no noticeable pathology resulted nor could a
During the acclimation period, the animals were submitted to incremental hypertrophic response be detected at the molecular or perimental trial from each group of animals (*P,0.05). MyBP-C mice exhibit a significantly increased exercise capacity relative to both MyBP-C.wt and NTG animals.
Altering the phosphorylation status of the contractile apparatus via genetics
protein is incorporated normally into the sarcomere at the To date, biochemical methodology in which different A-band in a manner indistinguishable from the endogenous target proteins are partially or completely extracted from protein. We focused on lines in which only partial replacemyofibrillar samples, followed by the subsequent reconsti-D9 ment (35%) of MyBP-C with MyBP-C protein occurred, tution of the contractile apparatus and measurement of the in order to mimic modulation of phosphorylation levels as functional outcomes have been used to dissect the role that they occur in vivo. Removal of a subset of phosphorylation phosphorylation can play in regulating cardiac contraction sites in MyBP-C resulted in increased endogenous phos- [23] [24] [25] . While these studies are informative, functional phorylation levels in the remaining MyBP-C as well as in outcomes at the whole organ and whole animal levels have TnI and PLB and, in fact, may potentiate the heart's ability not been possible. The transgenic approach, when carefully to respond to chronic stress. These compensatory changes controlled, allows one to examine the long-term consemay partially explain the rather benign phenotype that quences in the animal of diminished phosphorylation of resulted and the increases in certain performance paramecardiac MyBP-C. It is important to note that the mutated ters. Not only was there an absence of morbidity, mortality, pathology, and a hypertrophic response, but the animals to be affected in the MyBP-C animals. Therefore, our genetic change that modifies the phosphorylation status of current approach is to generate a series of animals in which MyBP-C in particular, and myofibrillar proteins in general. the different phosphorylation sites are ablated, both in MyBP-C as well as in MLC2v, phospholamban, the L-type 21 Ca channel, TnI and TnT. As these animals are made the
